Skip Navigation

JNCI Journal of the National Cancer Institute 2007 99(1):11-13; doi:10.1093/jnci/djk039
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hede, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hede, K.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

NEWS

Efforts To Communicate Clinical Trial Results to Patients Face Uphill Climb

Karyn Hede

The first 150 words of the full text of this article appear below.

In the post-Vioxx era, clinical researchers are beginning to embrace openness and greater transparency in an effort to restore patient confidence. Awareness campaigns and publicly accessible clinical trials registries are a few of the new efforts to improve the public perception of clinical trials. But a few would-be reformers are suggesting another way to boost public confidence: Offer clinical trial participants the opportunity to be told their outcome.

"There is a lot of suspicion about clinical trials and what they represent," said Antonio Wolff, M.D., associate professor of oncology at Johns Hopkins Kimmel Cancer Center in Baltimore. "By offering results, we are empowering patients and reinforcing to them and to their family and friends the individual and societal value of clinical research. That could indirectly, by word of mouth, have a positive impact on recruitment."

Wolff has begun a conversation among members of the American Society of Clinical Oncology's health . . . [Full Text of this Article]

Why Doctors Don't Share Data


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Oncology Physician and Nurse Practices and Attitudes Regarding Offering Clinical Trial Results To Study Participants
Ann H. Partridge, Nadia Hackett, Emily Blood, Rebecca Gelman, Steven Joffe, Susan Bauer-Wu, Katherine Knudsen, Karen Emmons, Deborah Collyar, Richard L. Schilsky, and Eric P. Winer
J Natl Cancer Inst 2004 96: 629-632. [Abstract] [Full Text] [PDF]

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17
Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David A. Cameron, Michael J. Palmer, and Joseph L. Pater
J Natl Cancer Inst 2005 97: 1262-1271. [Abstract] [Full Text] [PDF]